Table 1.

Demographic Data of Patients with TAO and Controls.

	Patients with TAO	Control subjects	P
No. of participants	40	18
Sex, M/F	24/16	6/12	0.06
Age, mean ± SD (range), y	50.53 ± 12.57 (24-79)	46.39 ± 20.82 (24-75)	0.602
Clinical activity score			NA
Stable	19
Active	21
Duration of TAO, median (range), m	22 (2 - 120)		NA
Therapy history			NA
Thyroid surgery	3/40
Orbital irradiation	1/40
Steroid treatment	40/40
Thyroid function			NA
Hyperthyroid	0/40
Hypothyroid	3/40
Euthyroid	37/40

TAO, Thyroid-associated ophthalmopathy; M, male; F, female; SD, standard deviation; y, year; m, month; NA, not applicable.